HYPHARCO

MOST

Innovative hybrid catalysts (inorganic and enzymatic) for continuous heterogeneous pharmaceutical processes

The project concerns the development of innovative catalytic materials able to take up the challenge presently launched by the pharmaceutical industry: synthetizing pharmaceutically relevant molecules in continuous flow reactors with fixed bed catalysts.

Our lab is in charge of the formulation of an alternative catalyst, more adapted to a continuous flow process, indeed and even capable of developping a synergy with enzymatic catalysts

Financing:

Région Wallonne
FRIA grants